179 related articles for article (PubMed ID: 21396847)
1. RET protein expression in papillary renal cell carcinoma.
Flavin R; Finn SP; Choueiri TK; Ingoldsby H; Ring M; Barrett C; Rogers M; Smyth P; O'Regan E; Gaffney E; O'Leary JJ; Loda M; Signoretti S; Sheils O
Urol Oncol; 2012; 30(6):900-5. PubMed ID: 21396847
[TBL] [Abstract][Full Text] [Related]
2. Expression of the Na+/K+-transporting ATPase gamma subunit FXYD2 in renal tumors.
Gaut JP; Crimmins DL; Lockwood CM; McQuillan JJ; Ladenson JH
Mod Pathol; 2013 May; 26(5):716-24. PubMed ID: 23196795
[TBL] [Abstract][Full Text] [Related]
3. Expression and Distribution of Galectin-3 in Chromophobe and Papillary Carcinomas.
Cioca A; Muntean D; Bungardean C; Raica M; Cimpean AM
Anticancer Res; 2018 Jan; 38(1):259-263. PubMed ID: 29277781
[TBL] [Abstract][Full Text] [Related]
4. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
[TBL] [Abstract][Full Text] [Related]
5. Immunostaining characteristics of irisin in benign and malignant renal cancers.
Kuloğlu T; Artaş G; Yardim M; Sahin I; Aydin Y; Beyoğlu N; Özercan IH; Yalcin MH; Ugur K; Aydin S
Biotech Histochem; 2019 Aug; 94(6):435-441. PubMed ID: 30896263
[TBL] [Abstract][Full Text] [Related]
6. MET expression in sporadic renal cell carcinomas.
Choi JS; Kim MK; Seo JW; Choi YL; Kim DH; Chun YK; Ko YH
J Korean Med Sci; 2006 Aug; 21(4):672-7. PubMed ID: 16891811
[TBL] [Abstract][Full Text] [Related]
7. [Expression of Ksp-cadherin in renal epithelial neoplasm and its clinicopathologic significance].
Rao Q; Zhou XJ; Shi QL; Yin HL; Ma HH; Zhou HB; Zhang RS
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):15-8. PubMed ID: 17374232
[TBL] [Abstract][Full Text] [Related]
8. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling.
Hornsby CD; Cohen C; Amin MB; Picken MM; Lawson D; Yin-Goen Q; Young AN
Arch Pathol Lab Med; 2007 Oct; 131(10):1541-6. PubMed ID: 17922590
[TBL] [Abstract][Full Text] [Related]
9. Paxillin: application of immunohistochemistry to the diagnosis of chromophobe renal cell carcinoma and oncocytoma.
Kuroda N; Guo L; Toi M; Naruse K; Miyazaki E; Hayashi Y; Yoshikawa C; Ashida S; Shuin T; Enzan H
Appl Immunohistochem Mol Morphol; 2001 Dec; 9(4):315-8. PubMed ID: 11759057
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil gelatinase-associated lipocalin immunoexpression in renal tumors: correlation with histotype and histological grade.
Barresi V; Ieni A; Bolignano D; Magno C; Buemi M; Barresi G
Oncol Rep; 2010 Aug; 24(2):305-10. PubMed ID: 20596614
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of extensive necrosis in renal cell carcinoma.
Collins J; Epstein JI
Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
[TBL] [Abstract][Full Text] [Related]
12. Vascular cell adhesion molecule 1 predicts cancer-free survival in clear cell renal carcinoma patients.
Shioi K; Komiya A; Hattori K; Huang Y; Sano F; Murakami T; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
Clin Cancer Res; 2006 Dec; 12(24):7339-46. PubMed ID: 17189405
[TBL] [Abstract][Full Text] [Related]
13. Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture.
Michalova K; Tretiakova M; Pivovarcikova K; Alaghehbandan R; Perez Montiel D; Ulamec M; Osunkoya A; Trpkov K; Yuan G; Grossmann P; Sperga M; Ferak I; Rogala J; Mareckova J; Pitra T; Kolar J; Michal M; Hes O
Ann Diagn Pathol; 2020 Feb; 44():151448. PubMed ID: 31918172
[TBL] [Abstract][Full Text] [Related]
14. Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancer.
Möller K; Fraune C; Blessin NC; Lennartz M; Kluth M; Hube-Magg C; Lindhorst L; Dahlem R; Fisch M; Eichenauer T; Riechardt S; Simon R; Sauter G; Büscheck F; Höppner W; Matthies C; Doh O; Krech T; Marx AH; Zecha H; Rink M; Steurer S; Clauditz TS
Int Urol Nephrol; 2021 Dec; 53(12):2493-2503. PubMed ID: 33797012
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
16. Expression of Galectin-3 in renal neoplasms: a diagnostic, possible prognostic marker.
Dancer JY; Truong LD; Zhai Q; Shen SS
Arch Pathol Lab Med; 2010 Jan; 134(1):90-4. PubMed ID: 20073610
[TBL] [Abstract][Full Text] [Related]
17. A promising biomarker to distinguish benign and malignant renal tumors: ELABELA.
Artas G; Kuloglu T; Dagli AF; Ugur K; Yardim M; Aydin S; Artas H; Kocdor H
Niger J Clin Pract; 2019 Mar; 22(3):386-392. PubMed ID: 30837428
[TBL] [Abstract][Full Text] [Related]
18. S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma.
Li G; Barthelemy A; Feng G; Gentil-Perret A; Peoc'h M; Genin C; Tostain J
Histopathology; 2007 Apr; 50(5):642-7. PubMed ID: 17394501
[TBL] [Abstract][Full Text] [Related]
19. Expression of the EphA1 protein is associated with Fuhrman nuclear grade in clear cell renal cell carcinomas.
Wang X; Liu Y; Cao G; Zhang X; Xu H; Xu H; Wang J
Int J Clin Exp Pathol; 2015; 8(6):6821-7. PubMed ID: 26261568
[TBL] [Abstract][Full Text] [Related]
20. Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study.
Mazal PR; Stichenwirth M; Koller A; Blach S; Haitel A; Susani M
Mod Pathol; 2005 Apr; 18(4):535-40. PubMed ID: 15502805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
